TCBPY (TC BioPharm (Holdings)) Other Current Liabilities: $0.00 Mil (As of Dec. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is TC BioPharm (Holdings) Other Current Liabilities?

TC BioPharm (Holdings) TCBPY Other Current Liabilities is $0.00 Mil as of Dec. 2024.

TC BioPharm (Holdings)'s other current liabilities for the quarter that ended in Dec. 2024 was $0.00 Mil.

TC BioPharm (Holdings)'s quarterly other current liabilities declined from Dec. 2023 ($0.02 Mil) to Jun. 2024 ($0.00 Mil) and declined from Jun. 2024 ($0.00 Mil) to Dec. 2024 ($0.00 Mil).

TC BioPharm (Holdings)'s annual other current liabilities declined from Dec. 2022 ($7.34 Mil) to Dec. 2023 ($0.02 Mil) and declined from Dec. 2023 ($0.02 Mil) to Dec. 2024 ($0.00 Mil).

TC BioPharm (Holdings) Other Current Liabilities Related Terms

TC BioPharm (Holdings) Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for TC BioPharm (Holdings)'s Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TC BioPharm (Holdings) Other Current Liabilities Chart

TC BioPharm (Holdings) Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Current Liabilities
Get a 7-Day Free Trial 0.00 9.21 7.34 0.02 0.00

TC BioPharm (Holdings) Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.34 1.77 0.02 0.00 0.00

TC BioPharm (Holdings) Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of $0.00 Mil mean?
TC BioPharm (Holdings) (TCBPY) has a Other Current Liabilities of $0.00 Mil as of Dec. 2024. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on TC BioPharm (Holdings).
Is TC BioPharm (Holdings)'s Other Current Liabilities too high?
TC BioPharm (Holdings)'s current Other Current Liabilities is $0.00 Mil.
How does TC BioPharm (Holdings)'s Other Current Liabilities compare to SIGY and CNBX?
TC BioPharm (Holdings)'s Other Current Liabilities of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Biotechnology company?
A good Other Current Liabilities depends on the Biotechnology industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on TC BioPharm (Holdings). TC BioPharm (Holdings)'s current Other Current Liabilities is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TC BioPharm (Holdings) stock overvalued right now?
TC BioPharm (Holdings) (TCBPY) has a current Other Current Liabilities of $0.00 Mil. The current Other Current Liabilities is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For TC BioPharm (Holdings) (TCBPY), the current Other Current Liabilities is $0.00 Mil as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

TC BioPharm (Holdings) Business Description

Address Maxim 1, 2 Parklands Way, Holytown, Motherwell, Scotland, GBR, ML1 4WR
TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform. Harnessing the innate ability of GD-Ts has enabled the company to develop a range of clinical-stage cell therapies designed to combat cancer and viral infection.